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Mouse modelDetailed studies describing the pathogenesis of Rift Valley fever (RVF) virus (RVFV) in the mouse model are
lacking. A fully characterized small animal model of RVF is needed to evaluate potential vaccines and
therapeutics. In this study, we characterized the pathogenesis of RVFV throughout the disease course in mice.
Infection produced high-titer viremia and demonstrated RVFV tropism for a variety of tissue and individual
cell types. Overwhelming infection of hepatocytes, accompanied by apoptosis, was a major consequence of
infection. The majority of mice died or were euthanatized between days 3 and 6 postinfection with severe
hepatitis. The remaining mice effectively cleared virus from the liver and blood, but exhibited neuroinvasion
and developed panencephalitis. In addition, we characterized a number of other virological, clinicopatho-
logical, and histopathological features of RVFV infection in mice. The mouse model therefore mimics both the
acute-onset hepatitis and delayed-onset encephalitis that are dominant features of severe human RVF., 1425 Porter St., Fort Detrick,
th).
Countermeasures Center, 110
Inc.Published by Elsevier Inc.Introduction
An important hemorrhagic fever virus lacking attention in recent
years is Rift Valley fever virus (RVFV). RVFV is classiﬁed as a category
A, or high-priority agent, by the National Institute for Allergy and
Infectious Diseases (NIAID), is on the Centers for Disease Control and
Prevention (CDC) bioterrorism agent list, and is classiﬁed as a
Department of Health and Human Services (HHS), United States
Department of Agriculture (USDA) overlap select agent. RVFV is a
member of the Bunyaviridae family, genus Phlebovirus, and is a
negative sense, single-stranded RNA virus. The RVFV genome is
tripartite and consists of large (L), medium (M), and small (S)
segments which encode a total of seven proteins. The virus was ﬁrst
isolated in 1930 in East Africa (Daubney et al., 1931) and has since
caused severe epidemics and epizootics throughout Africa and, more
recently, the Arabian Peninsula (Bird et al., 2009; Meegan and Bailey,
1989). Severe outbreaks have involved tens of thousands of both
human and livestock cases. Human cases have been reported in much
of Africa, Saudi Arabia, and Yemen, with recent outbreaks in Kenya
during 2006–2007 (Bird et al., 2009).
RVFV is an arthropod-borne virus (arbovirus) which is transmitted
primarily by mosquitoes in the Aedes or Culex genera. Livestock
infections with RVFV are usually recognized by the onset of abortion
“storms” that sweep through livestock-producing areas. The suscep-tibility of livestock to RVFV infection varies considerably and depends
on livestock species, age, and viral strain (Schmaljohn and Nichol,
2007). Humans may become infected when fed upon by infected
arthropods or by contact with tissues, blood, or ﬂuids from infected
animals. Acute febrile disease in humans often occurs simultaneously
with livestock infections. After an incubation period of 2 to 6 days, an
abrupt onset of fever, chills, and general malaise ensues. Inmost cases,
the disease is mild, and recovery occurs without major consequences.
Severe cases, however, which affect around 1–3% of infected
individuals, are characterized by acute-onset liver disease, delayed-
onset encephalitis, retinitis, blindness, or a hemorrhagic syndrome,
with a case fatality rate of 10–20% in hospitalized individuals
(Laughlin et al., 1979; Madani et al., 2003; McIntosh et al., 1980).
Similar to other arboviruses, the pathogenesis of RVFV infection
after natural transmission by an infected mosquito most likely results
in the virus being transported from the inoculation site to regional
lymph nodes by the lymphatic system. Early viral replication occurs in
the lymph nodes, resulting in a primary viremia, spread via the
bloodstream, and infection of target organs. Major sites of viral
replication reportedly include the liver, spleen, and often the brain of
animals dying from encephalitis (Flick and Bouloy, 2005). Pathologic
features of RVF in livestock and humans can vary considerably.
Leukopenia is often observed during the ﬁrst 3 or 4 days of infection
which is also when fever and viremia are at their peak. During the
acute phase, serum enzyme levels are often altered, which indicates
hepatocyte destruction. Infection of pregnant animals often results in
abortion of the fetus. However, no correlation has been observed for
humans infected with RVFV and the occurrence of abortions. During
the early phase of recovery, leukocytosis is often prominent.
Disseminated intravascular coagulation (DIC) may be a feature of
Fig. 1. Survival of mice (N=10) infected s.c. with 1000 PFU of RVFV.
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thrombi observed in several organs of infected livestock. This feature is
also observed in human hemorrhagic infections (Schmaljohn and
Nichol, 2007).
Several animal models of RVFV infection have been described.
These may be useful in understanding the nature of key pathogenetic
processes applicable to human infections or for the development and
testing of vaccines and therapeutic agents. As such, they have the
potential to satisfy key provisions of the Food and Drug Adminis-
tration's (FDA) ‘Animal Rule,’ which allows for the demonstration of
drug or vaccine efﬁcacy using animal studies instead of human clinical
trials (Snoy, 2010). Mice are highly susceptible to infection with RVFV
by subcutaneous (s.c.) or intraperitoneal (i.p.) injection leading to
fulminant hepatitis and a late-developing encephalitis (Findlay, 1931;
Flick and Bouloy, 2005; Mims, 1956; Peters and Linthicum, 1994).
Similar to mice, hamsters and rats are also susceptible to infection
(Findlay, 1932, 1931; Flick and Bouloy, 2005; Peters and Linthicum,
1994). Both hepatitis and encephalitis have been described in rats;
however, their susceptibility to RVFV can vary signiﬁcantly depending
on the strain of rat used, and usually only one pathologic feature (i.e.,
hepatitis or encephalitis) is observed in a particular strain (Anderson
et al., 1987; Flick and Bouloy, 2005; Peters and Linthicum, 1994; Ritter
et al., 2000). Resistance in these rats is governed by a dominant
Mendelian gene (Anderson et al., 1991). The hamstermodel has relied
mainly on experimental infection with the related bunyavirus Punta
Toro (Anderson et al., 1990; Fisher et al., 2003) where only hepatitis
(but not encephalitis) is the dominant pathologic feature. In addition,
gerbils infected with RVFV reportedly develop uniformly fatal
encephalitis in the absence of signiﬁcant extraneural lesions (Ander-
son et al., 1988). To date, none of the reported animal models of RVFV
has been described in extensive detail. For example, no in-depth
studies have addressed important questions such as viral titers in
speciﬁc tissues, speciﬁc types of infected cells, and histopathological
changes over the course of infection. These types of studies are needed
to develop and validate models to screen candidate therapeutic
measures as well as to better understand the pathogenesis of RVF to
identify new targets for clinical intervention.
Here we describe a number of disease features in a lethal BALB/c
mousemodel of RVFV in which acute-onset liver disease and delayed-
onset encephalitis were key manifestations. RVFV infection produced
high-titer viremia and demonstrated tropism for a variety of tissue
and individual cell types. Overwhelming infection of hepatocytes in
particular, accompanied by hepatocyte apoptosis, was a major
consequence of infection. The majority of mice died between days 3
and 6 postinfection (PI) with severe hepatitis. The remaining mice
effectively cleared virus from the liver and blood but exhibited
neuroinvasion and developed panencephalitis. In addition, we
characterized a number of other virological, clinicopathological, and
histopathological features of RVFV infection in mice. This study
established the basic pathogenesis of RVFV in a mouse model and
showed important similarities to severe human infections. Accord-
ingly, it should provide the basis for additional studies needed to
further deﬁne critical pathogenetic processes relevant to human
disease. This mouse model could eventually prove useful in the
development and evaluation of therapeutics and vaccines under the
FDA animal rule.
Results
Survival and viral titers
Mice were highly susceptible to the ZH501 strain of RVFV where
the LD50 for this strain was determined to be 8.5 PFU. Signs of clinical
illness become apparent on day 2 PI at which time the mice presented
with rufﬂed fur. By day 3 PI, illness was more pronounced, whereas
the majority of mice exhibited rufﬂed fur, hunched posture, and werepoorly responsive. Over half of the mice succumbed or were
euthanatized on day 3 PI (Fig. 1). Mice that succumbed or were
euthanatized around day 8–9 PI exhibited signs of encephalitis such as
hind limb paralysis.
The viral titers in the sera, liver, spleen, brain, inguinal lymph node,
heart, kidney, lung pancreas, large intestine, adrenal glands, ovaries,
and eyes were determined by standard plaque assay on days 1–6 and
day 8 PI (Fig. 2). No virus was detected in the sera or in any tissues
until day 2 PI. On day 3 PI, the mean titer in the blood was 5.5 log10
PFU/ml. However, viremia did not peak until day 6 PI when it was
slightly higher with a mean of 7 log10 PFU/ml. For other tissues, virus
was ﬁrst detected on day 2 PI in the liver, spleen, inguinal lymph node,
and kidney (Fig. 2A) and in the lung and adrenal gland (Fig. 2B). Viral
titers in these tissues generally increased thereafter, peaking on day 6
PI. Virus ﬁrst appeared in the brain and heart (Fig. 2A) and the ovaries
and eyes (Fig. 2B) on day 3 PI followed by a peak on day 6 PI. Virus was
detected in all tissues analyzed on day 5 PI which peaked on day 6 PI
followed by a sharp decrease in virus in all tissues on day 8 PI. In fact,
virus was no longer detected in the sera, liver, lung, pancreas, large
intestine, and ovaries by day 8 PI.Clinical chemistry and hematology
The blood chemistry and CBC values were determined in the
uninfected controls (day 0 PI) and the infected mice on days 1–6 and
day 8 PI (Figs. 3 and 4). No signiﬁcant differenceswere detected on day
1 or 2 PI for all analytes. On day 3 PI, the liver enzymeswere found to be
signiﬁcantly different [alanine aminotransferase (ALT), pb0.0001;
alkaline phosphatase (ALP), p=0.0088] compared to the uninfected
control mice. The liver enzymes remained signiﬁcantly elevated until
day 8 PI (Figs. 3A and B). On days 5 and 6 PI, the albumin (ALB) and
total bilirubin (TBIL) levels were signiﬁcantly different compared to
uninfected controls (pb0.05; Figs. 3C and D). The ALB levels decreased
signiﬁcantly, whereas the TBIL levels increased signiﬁcantly and
suggested a hepatic disorder. Amylase levels were also signiﬁcantly
higher on day 3 PI (data not shown). For the CBC results, a signiﬁcant
decrease in percent lymphocytes (p=0.0058 to b0.0001; Fig. 4A) and
a signiﬁcant increase in percent neutrophils (p=0.017 to b0.0001;
Fig. 4B) was observed on days 3–6, and day 8 PI compared to
uninfected controls. Also of signiﬁcant increase (p=0.0272 to
b0.0001) were the RBC (Fig. 4C) and hemoglobin (Hb; Fig. 4D) levels
on days 3–5 PI compared to uninfected controls. Other analytes
showing signiﬁcant increases compared to uninfected mice were the
percent eosinophils (p=0.0065) and basophils (p=0.0209) on day 5
PI, the hematocrit levels on days 4 (p=0.0003) and 5 PI (p=0.0278),
Fig. 2. Viral titers in sera and tissues of infected mice. (A) Sera, liver, spleen, inguinal lymph node, brain, heart, and kidney. (B) Lung, pancreas, large intestine, adrenal gland, ovaries,
and eyes. N=3 mice/day PI. Error bars represent mean standard deviation.
258 D.R. Smith et al. / Virology 407 (2010) 256–267and the red cell distribution width on day 3 PI (p=0.0026; data not
shown).
Histopathology
The gross pathology ﬁndings were limited to multiple white foci in
the liver (hepatic necrosis) and hemorrhage in the large intestines,
both apparent on day 3 PI, and hemorrhage in the brain at day 8 PI.
Overall, and generally consistent with virus titration studies,
immunohistochemistry demonstrated that RVFV targeted multiple
tissues and a diverse set of cell types in the mice of this study. Key
tissues in which substantial amounts of viral antigen were present
included the liver (Fig. 5), brain (Fig. 6), various lymphoid tissues
(Fig. 7), heart, lungs, kidneys, and adrenal glands (Fig. 8). Speciﬁc
types of immunolabeled cells identiﬁed morphologically included
epithelial cells (hepatocytes, adrenocortical cells, odontogenic epi-
thelium, gingival epithelium), mesenchymal cells (perineural cells,periosteal and endosteal cells, perivascular cells, bone marrow
stromal cells, ﬁbroblastic reticular cells, cardiac myoﬁbers, vascular
smooth muscle cells, lipocytes), neural cells (olfactory neurons and
multiple types of neurons in the brain), hematopoietic cells
(mononuclear phagocytes and cells morphologically consistent with
dendritic cells), and endocrine cells (pancreatic islet cells, adrenal
medullary cells, pituicytes). Ocular structures, including the retina,
were negative in all cases. Endothelial cells did not appear to be
targets of infection either, although strong staining of the blood in
many vessels made visualization of some endothelial cells difﬁcult.
The amounts of viral antigen in different tissues and individual cell
types varied signiﬁcantly depending on the time at which mice were
euthanatized. Immunohistochemistry failed to indicate the presence
of virus in any tissues at day 1 PI. Viral antigen appeared in several
tissue locations beginning at day 2 PI, as described subsequently.
The liver was a major target of RVFV in these mice (Fig. 5). A few
infected hepatocytes were evident as early as day 2 PI (two of three
Fig. 3. Analysis of the (A) alanine aminotransferase (ALT), (B) alkaline phosphatase (ALP), (C) albumin (ALB), and (D) total bilrubin (TBIL) levels in the blood of RVFV-infected mice
(N=2–3/day PI). The bar indicates the mean concentration and the error bars represent mean standard deviation.
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four mice (Fig. 5B). In particular, hepatocytes were the overwhelming
cellular target of RVFV in the liver. A few immunolabeled Kupffer cells
were also noted at day 2; however, the numerous immunolabeled
hepatocytes at later times made it difﬁcult to identify additional types
of infected cells. Despite such extensive infection of hepatocytes,
clearance of virus from the liver occurred to a great extent inmice that
survived to later time points, as reduced amounts of viral antigen
were evident at day 6 PI (Fig. 5C). No antigen was detected in the
livers of either mouse euthanatized at day 8 PI. The course of infection
of the liver demonstrated by immunohistochemistry was further
evident in the levels of RVFV antigen determined by image analysis
(Fig. 5D).
The main early histological change was hepatocellular death due
to apoptosis (Figs. 5E and F). Affected hepatocytes exhibited hallmark
morphological features of apoptosis including cell shrinkage and
rounding, pyknosis, karyorrhexis, and the presence of apoptotic
bodies. This was evident in all mice at day 3 PI, and was accompanied
by some hemorrhage. In addition, eosinophilic intranuclear inclusions
were evident in hepatocytes at day 3 and later times (Fig. 5F),
although it is not certain if these represent viral inclusions. At day 4 PI,
hepatocyte apoptosis was further accompanied by increasingly severe
degeneration of hepatic cord structure and foci of hepatocellular
damage contained some inﬁltrating neutrophils. At later times,
inﬂammatory foci were more prominent and contained greater
numbers of lymphocytes. In some liver sections, lymphocytes were
immediately adjacent to, and indented, the cell membrane of
immunolabeled hepatocytes (Fig. 5G). Presumably these lymphocytes
represented CD8+ cytotoxic T cells, although we have yet to examine
such a possibility by speciﬁc methods. Hepatocellular regeneration
was initially seen at day 6 PI (Fig. 5H). At day 8 PI, liver repair wasfurther evident, as most hepatocytes appeared morphologically
normal (albeit with abundant microvesicular cytoplasm) and a
greater semblance of hepatic cord structure was present.
Infection of the brain was only apparent histologically late in the
course of infection (Fig. 6). Immunolabeled brain sections of all cases
were uniformly negative until day 5 PI, at which time two of the three
mice had minimal antigen in limited foci of basal brain structures. At
days 6 and 8 PI (Figs. 6A and B), the amounts of viral antigen were
more extensive and were present in most regions of the brain. Brain
lesions were not prominent until day 8 PI (Fig. 6C). Both cases at day
8 exhibited meningoencephalitis, characterized by the presence of
neuronal necrosis and microhemorrhages in multiple regions of the
brain; perivascular cuffs of viable and degenerate neutrophils,
lymphocytes and macrophages; and inﬁltration of the neuropil by
neutrophils. In addition, meningeal inﬂammatory cell inﬁltrates
composed primarily of lymphocytes were present at this time. Before
day 8 PI, only one case (day 6 PI) exhibited histological changes in the
brain. This case had microhemorrhages limited to the olfactory bulb,
accompanied by degeneration of rare, unidentiﬁable cells. Possibly
related to infection of the brain, we did observe infection of the
olfactory mucosa (Fig. 6D) and teeth (Fig. 7E) at day 3 PI and later. We
note these ﬁndings here because they could be relevant to the process
of neuroinvasion; e.g., RVFV might enter the brain subsequent to
infection of cranial nerves I (olfactory) and V (trigeminal). There was
also infection of perineural ﬁbroblasts surrounding other cranial
nerves (Fig. 7D), potentially providing an additional means of
neuroinvasion.
Lymphoid tissues were also commonly affected by RVFV. Splenic
infection was evident at day 2 PI (one of three mice) as limited viral
antigen in mononuclear phagocytes or cells morphologically compat-
ible with dendritic cells (Fig. 7A) of the outer periarteriolar lymphoid
Fig. 4. Analysis of the percent (A) lymphocytes, (B) neutrophils, (C) red blood cells (RBCs), and (D) hemoglobin (Hb) in RVFV-infected mice (N=2–6/day PI). The bar indicates the
mean concentration and the error bars represent mean standard deviation.
260 D.R. Smith et al. / Virology 407 (2010) 256–267sheath andmarginal zone. The spleen and a number of lymph nodes of
all mice contained viral antigen at days 3, 4, and 5 PI. Most of the viral
antigen in the spleen was represented by free granular deposits in the
red pulp. The thymus contained a few immunolabeled cells in all three
cases at day 2 PI. Infected cell types included apparent dendritic cells,
macrophages, and thymic epithelial cells. Similar amounts of viral
antigen were present in the thymus at later times (Fig. 7B). In the
lymph nodes, there was prominent immunolabeling of ﬁbroblastic
reticular cells (FRCs). Sinus-lining cells and sinus-crossing cells were
the main types of FRCs immunolabeled for RVFV antigen (Fig. 7C).
Somemononuclear phagocytes and apparent dendritic cells were also
evident, although these were not abundant. A number of additional
cell types, as previously noted, were immunolabeled in various tissues
in mice euthanatized at days 3, 4, and 5 PI (Figs. 7D–H).
The main lymphoid lesion was one of lymphocyte apoptosis
(lymphocytolysis), seen in the thymus, spleen, lymph nodes, and
mucosa-associated lymphoid tissues. This was ﬁrst evident in all mice
at day 3 PI andwas also present at day 4 PI. Lymphocyte apoptosis was
observed both in foci that contained RVFV antigen and in foci that did
not (Fig. 7B). The lymphocytes themselves did not appear immuno-
labeled. Some lymphoid regenerationwas evident by day 5 PI, and this
change progressed to outright lymphoid hyperplasia by day 8 PI. We
also noted depletion of the red pulp, likely representing physiological
splenic contraction, in several cases at day 3 PI and later. In addition,
reduced numbers of myeloid cells were evident in the splenic red pulp
and bone marrow of several cases at days 3 and 4 PI. There was
myeloid hyperplasia, however, by day 8 PI. Lesions in other tissues
were typically milder than those already described. Such lesions were
essentially small foci of cell death by apoptosis or necrosis in a variety
of locations.Electron microscopy
Similar to our histopathological results, electron microscopy
demonstrated ultrastructural features of hepatocellular and lympho-
cyte death consistent with apoptosis (Figs. 9A and B). Apoptotic
hepatocytes were evident in all mice at day 3 PI. The livers of affected
mice exhibited hepatocytes with condensed chromatin, often mar-
ginated along the nuclear envelope (pyknosis), as well as karyorrhexis
and apoptotic bodies. The cytoplasm of hepatocytes also had
abundant lipid droplets and degenerate organelles, which is in
contrast to uninfected mice (Fig. 9C). In addition, apoptosis of splenic
lymphocytes was evident in all infected mice at day 3 PI (Figs. 9D and
E), whereas uninfected mice demonstrated regular nuclear morphol-
ogy (Fig. 9F).
Terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling
(TUNEL)
TUNEL conﬁrmed the histological and ultrastructural ﬁndings of
apoptotic cells in the liver and spleen (Figs. 10A and B). By day 3 PI,
labeled hepatocytes were clearly evident in liver sections. Other
labeled cells appeared to be Kupffer cells, hepatic stellate cells, or
sinusoidal endothelial cells; however, many labeled cells lacked
sufﬁcient morphological detail to identify them. In the spleen, there
was similar labeling of numerous individual cells or small foci of cells
in the white pulp with morphological features of apoptotic lympho-
cytes. Individual labeled cells were also present scattered throughout
the red pulp. In contrast, liver and spleen sections of uninfected mice
demonstrated only a few, widely scattered TUNEL-positive cells
(Figs. 10C and D). The average scores for TUNEL-positive cells ranged
Fig. 5. Histopathological and immunohistochemical ﬁndings in the liver. (A–C) Immunohistochemistry demonstrates the amounts of RVFV antigen in the livers (primarily
hepatocytes) typical of mice euthanatized at days 2 (A), 3 (B), and 6 (C) PI. (D) Quantitative assay of viral antigen in liver sections shows changes throughout the course of infection.
(E) Rounded hepatocytes with marginated nuclear chromatin (white arrowhead) or condensed nuclei and scattered apoptotic bodies throughout (black arrowheads) the liver
demonstrate hepatocyte apoptosis at day 3 PI. (F) Viable and degenerate neutrophils, macrophages, and lymphocytes inﬁltrate a focus of damaged liver of a mouse at day 5 PI; note
the presence of eosinophilic intranuclear inclusion-like material (arrowheads). (G) A focus of degenerate cells with viral antigen is inﬁltrated bymostlymononuclear cells in amouse
at day 6 PI; note the presence of two lymphocytes (arrowheads) appearing to attack an infected hepatocyte. (H) Overall basophilia and the presence of numerous viable hepatocytes
demonstrate liver regeneration in another mouse at day 6 PI; note the presence of microvesicular cytoplasm (black arrowhead) in numerous hepatocytes as well as some remaining
apoptotic bodies (white arrowheads) and inﬂammatory cells (*). Immunoperoxidase method with hematoxylin counterstain (A, B, C, G) and routine HE stain (E, F, H); automated
digital image analysis was used to measure RVFV antigen (D).
261D.R. Smith et al. / Virology 407 (2010) 256–267from 3 to 4+ in the liver and from 2 to 3+ in the spleen of infected
animals (compared to rare immunopositive sinusoidal lining cells in
the liver and 1+ in the spleen in the uninfected control animals).
Summary
Asummaryof the changes observedduring thedisease course in the
mouse is depicted in Fig. 11. No changeswere detected until day 2 PI, atwhich time virus was detected by plaque assay and immunohisto-
chemistry in certain tissues.Mice began to succumb as early as day 3 PI,
when an overwhelming infection of the liver was apparent, accompa-
nied by a peak in liver enzymes. Virus began to spread to other tissues
and showed tropism formultiple cell types by day 5 PIwith infection of
the brain being detected by day 6 PI. Despite an overwhelming
infection of the liver, some mice were able to begin clearing virus, but
then appeared to succumb to encephalitis around day 8 PI.
Fig. 6. Histopathological and immunohistochemical ﬁndings in the brain and olfactory tract. (A) RVFV antigen is abundant in several brain structures at the level of the optic chiasm
(OC) in a mouse euthanatized at day 8 PI, including septal nuclei (arrowhead) and the olfactory tubercles. (B) Antigen is also abundant in the caudal brainstem of the same mouse,
including several large neurons and a few smaller cells (arrowheads) that likely represent glial cells. (C) A perivascular cuff of mononuclear cells and neutrophils and a few similar
cells inﬁltrating the neuropil are present in the same mouse as in A and B; note the presence of several necrotic neurons (arrowheads) in this ﬁeld. (D) A focus of olfactory mucosa
from a mouse at day 6 PI contains several olfactory neurons with RVFV antigen as well as a few spindloid cells (arrowheads) in the lamina propria surrounding ﬁla olfactoria (*).
Immunoperoxidase method with hematoxylin counterstain (A, B, D) and routine HE stain (C).
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The manifestations of acute-onset hepatitis and delayed-onset
encephalitis in mice infected with RVFV represent important
similarities to the most severe consequences of human RVF.
Accordingly, the mouse model could be very useful for investigating
key processes in the pathogenesis of RVF relevant to the human
disease. In that context, we describe a number of previously
unreported aspects of RVFV infection in mice inoculated peripherally
with a lethal dose of virus.
Overall, we found that a diverse group of tissues and cell types
were targets of RVFV in mice. In particular, determination of viral
titers and immunohistochemistry showed that the liver was a clear
early and dominant target of RVFV, with speciﬁc targeting of
hepatocytes. Infection resulted in extensive damage to hepatocytes
via apoptosis. This overwhelming infection of hepatocytes, evident byday 3 PI, correlated with the appearance of high levels of hepatic
enzymes in the blood at this time, along with increased bilirubin
levels, and decreased blood ALB levels by day 5 PI. Despite the
tropism of RVFV for numerous additional cell types, we attributed
infection of hepatocytes and hepatocellular damage to be the main
contributors to early lethality, also evident at day 3 PI. Mice that
survived this early phase of infection demonstrated eventual
clearance of virus from the liver and some other tissues, but
nonetheless developed infection of the brain. This neurologic phase
of disease culminated in spread of the virus throughout the brain and
panencephalitis terminally.
The route of neuroinvasion in mice that survived the hepatic phase
was unclear. However, there was evidence that virus may have
invaded the brain by at least two different means: (1) by way of the
olfactory nerves leading to infection of the olfactory bulbs and (2) by
ascending infection of cranial nerves into the brainstem. These
Fig. 7.Histopathological and immunohistochemical ﬁndings in lymphoid andmiscellaneous tissues. (A) RVFV antigen is present in a cell withmultiple dendritic processes (arrow) in
the outer white pulp of the spleen (presumed dendritic cell) of a mouse euthanatized at day 2 PI. (B) Foci of lymphocyte apoptosis are present in areas with and without RVFV
antigen in the thymus at day 3 PI. (C) RVFV antigen is present in sinus lining (white arrowhead) and sinus crossing (black arrowheads) ﬁbroblastic reticular cells of a mesenteric
lymph node at day 3 PI. (D–H) Viral infection of additional cell types in mice euthanatized at days 4 to 8 PI is evident by immunohistochemistry in perineural ﬁbroblasts of a cranial
nerve (D), odontogenic epithelial cells of a tooth (E), pancreatic islet cells (F), endosteal and periosteal cells (black arrowheads), and osteoblasts (white arrowhead) of the bone (G),
and vascular smoothmuscle cells of a renal vessel (H). Note the presence of numerous apoptotic cells in the bonemarrow (* –G) and the lack of immunolabeled endothelial cells (H).
Immunoperoxidase method with hematoxylin counterstain.
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routes used by other encephalitogenic viruses (Charles et al., 1995;
Monath et al., 1983). The speciﬁc means of neuroinvasion by RVFV in
mice inoculated peripherally nonetheless require further study.
Importantly, however, our observation that olfactory neurons lining
the nasal tract are a target of RVFV, and the implication that
neuroinvasion may consequently ascend to the olfactory nerves, like
other arboviruses, raise a concern that the incidence and severity of
central nervous system infection subsequent to aerosol infection may
be signiﬁcantly higher than is seen with peripheral infection. Addingto this concern is the recognition that RVFV is transmitted easily by
aerosol to humans, which is evident by the number of laboratory
workers who have become infected (Smithburn et al., 1949) and the
potential for infection of veterinarians and abattoir workers who
handle infected animals. However, the pathogenesis of RVFV after
aerosol exposure has never been described in the mouse model. The
meningoencephalitic form of RVF occurs in less than 1% of natural
human cases (Laughlin et al., 1979), but residual CNS symptoms are
common in neurological cases, and may be severe. In the context of
the tens of thousands of human cases that may arise during outbreaks,
Fig. 8. Immunohistochemistry illustrates typical amounts of viral antigen in the myocardium (A), lung (B), renal papilla (C), and adrenal gland (D). Immunoperoxidase method with
hematoxylin counterstain.
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medical challenge. Furthermore, the incidence of CNS manifestations
resulting from an intentional aerosol infection (e.g., biowarfare or
bioterrorism) could be much greater than is typical with peripheral
infection given the potential for neuroinvasion to occur through the
olfactory tract. Thus, future work should focus on this important route
of virus exposure by RVFV, which is considered a potential bioterror-
ism agent and is categorized as a category A, or high-priority, agent by
the CDC, USDA, and NIAID.
In addition to the liver and brain, lymphoid tissues were also
commonly affected. Themain lymphoid lesion was one of lymphocyte
apoptosis (lymphocytolysis), seen in the thymus, spleen, lymph
nodes, and mucosa-associated lymphoid tissues. These histological
changes correlated with the onset of lymphopenia. In the lymph
nodes, there was prominent immunolabeling of FRC, a type of pericyte
we previously demonstrated as a target of infection by Ebola,
Marburg, and Lassa viruses (Davis et al., 1997; Steele et al., 2009).
However, sinus-lining cells and sinus-crossing cells were the main
types of FRC immunolabeled for RVFV antigen, with fewer immuno-
labeled paracortical FRCs, as is typical of the other hemorrhagic fever
viruses we have studied. Lymphocyte apoptosis was observed in foci
that contained RVFV antigen and in foci that did not. Lymphocytes
themselves, however, did not appear immunolabled. These ﬁndings
suggest that lymphocyte damage was along the lines of so-called
“bystander apoptosis,” as previously described for Ebola and Marburg
viruses (Geisbert et al., 2000). Ebola and Marburg viruses also do not
directly infect lymphocytes, which is similar to our results, where
lymphocytes were not found to be infected with RVFV as detected by
IHC. Future studies should investigate the role RVFV has on
lymphocyte apoptosis, as these are important cells for the immune
response.
In addition, we observed aberrations in certain hematologic
parameters. For example, neutrophilia and lymphopenia occurred
concomitantly as early as day 3 PI. The increase in neutrophil levels
suggests the stimulation of a signiﬁcant inﬂammatory response,
which has also been observed in hemorrhagic ﬁlovirus infection
(Geisbert et al., 2003). Increased erythrocyte and hemoglobin values,
seen on days 3–5 PI, were attributed to dehydration and/orphysiological splenic contraction, which was also identiﬁed histolog-
ically as a depletion of the red pulp. As discussed previously, RVFV
targeted a variety of additional cell types. These might contribute in
subtle ways to lethal disease in the mouse model. For instance,
infection of muscle cells in the heart might contribute to cardiac
dysfunction, infection of vascular pericytes could promote vascular
leakage, or infection of endocrine cells could have a number of effects.
We did not observe evidence of hemorrhagic disease in the mouse
model. We did observe gross pathological evidence of hemorrhaging
in the large intestines, but we did not see evidence of ﬁbrin
deposition. This is similar to results observed in a mouse model of
Ebola virus infection where signiﬁcant signs of hemorrhagic disease
were not evident (Bray et al., 2001).
In conclusion, the murine model represents a good small animal
model for the evaluation of potential therapeutics and vaccines for
RVFV. The major pathological features of hepatitis and encephalitis
are reproduced in mice. Future work should characterize the
pathogenesis after aerosol exposure and further evaluate the immune
response to RVFV in mice.
Materials and methods
Viral strain
RVFV, strain ZH501, was isolated from a febrile human during the
1977 epidemic in Egypt and was passaged twice in fetal rhesus lung
cells, once in hamster, and once in baby hamster kidney (BHK) cells
before use. The lethal dose at 50% (LD50) of this strain was determined
to be 8.5 plaque-forming units (PFU) in BALB/c mice infected s.c. To
determine the LD50, ﬁve cohorts of mice comprised of 10 mice each
were inoculated with a range of doses (1000–0.1 PFU) and monitored
for survival.
Plaque assay
Plaque assays for RVFV used 90–100% conﬂuent Vero cells
(American Type Culture Collection, Manassas, VA) in 12-well plates.
Samples for titration were serially diluted 10-fold ,and 100 μL was
Fig. 9. Apoptosis of hepatocytes and splenic lymphocytes as demonstrated by transmission electron microscopy. (A, B) Apoptotic hepatocytes from amouse euthanatized on day 3 PI
display the hallmark apoptotic changes of pyknosis and karyorrhexis. (C) Hepatocytes from an uninfected control mouse. Note the distribution of chromatin in normal cells
compared with apoptotic cells. (D, E) Apoptosis of lymphocytes in the red pulp of the spleen from a mouse euthanatized on day 3 PI. (D) High-magniﬁcation image of four small
lymphocytes undergoing apoptosis. The morphological features evident in one or more cells include cell shrinkage (I), irregular nuclei with condensed chromatin (II), and
condensation of the cytoplasm. (E) Six lymphocytes undergo apoptosis exhibit similar morphological features. The appearance of one pyknotic lymphocyte suggests that this cell is
in a later stage of apoptosis (*). All bars=4 μm. (F) Lymphocytes in the red pulp of the spleen from an uninfected control mouse. Note the distribution of chromatin in normal cells
compared with apoptotic cells.
265D.R. Smith et al. / Virology 407 (2010) 256–267added to eachwell. Plates were incubated for 1 h at 37 °Cwith rocking
every 15 min. A primary overlay containing 1× EBME, 5% fetal bovine
serum (FBS), and 0.5% agarose was added to each well. Plates were
incubated at 37 °C/5% CO2 for 3 days followed by a secondary overlay,
which was the same as the primary overlay with the addition of 5%
neutral red. Plaques were counted on day 4 PI.
Pathogenesis study design
Female BALB/c mice were obtained from the National Cancer
Institute, Frederick Cancer Research and Development Center (Fre-
derick, MD) and were used when 6–8 weeks old. Mice were housed in
microisolator cages andwere providedwater and chow ad libitum. For
this study, mice were challenged s.c. with 1000 PFU of RVFV in a total
volume of 100 μL.
Four cohorts of mice were used to collect either blood for complete
blood count (CBC) and chemistry analysis, tissues for titration, tissues
for histopathology, or tissues for electronmicroscopy on days 0–6 and
day 8 PI. Three mice/cohort were used on each day PI except for day
8 PI (and except where indicated for chemistry analysis) where only
two mice were collected due to the limited number of animals
remaining. For one cohort, mice were deeply anesthetized and
exsanguinated by cardiac stick. Whole blood was added either to an
EDTA tube (Sarstedt, Numbrecht, Germany) for CBC determinationusing a Hemavet (Drew Scientiﬁc, Dallas, TX) or whole blood was
added to a lithium heparin tube (Sarstedt) for clinical chemistry
analysis using the comprehensive diagnostic panel analyzed on a
Vetscan (Abaxis, Union City, CA).
For the second cohort of mice, viral titers were evaluated in the
sera and tissues. Animals were anesthetized, bled retro-orbitally for
determination of viremia, and perfused with phosphate-buffered
saline (PBS) to remove blood containing virus from the tissues before
collection for titration. For perfusion, the heart was exposed, the right
atrium incised and PBS was injected into the left ventricle until the
ﬂuid emerging from the right atrium ran clear (or the mouse died).
Mice received, on average, 15-20 ml of PBS. The liver, spleen, brain,
inguinal lymph node, heart, kidney, lung pancreas, large intestine,
adrenal glands, ovaries, and eyes were collected, weighed, and
homogenized in EMEM containing 5% FBS and gentamicin. Tissues
were homogenized using the Qiagen Mixer Mill 300 (Retsch, New-
town, PA) then centrifuged at 10,000 rpm for 10 min and the
supernatant stored at −70 °C until further evaluation by standard
plaque assay to determine titers. For the third and fourth cohorts of
mice, tissues were collected for histopathology and electron micros-
copy (see below).
Research at USAMRIID was performed in compliance with the
AnimalWelfare Act and other federal statutes and regulations relating
to animals and experiments involving animals and adheres to
Fig. 10. TUNEL of the liver and spleen of infected and uninfectedmice. (A) There is widespread TUNEL labeling in the liver of an infectedmouse euthanatized on day 3 PI. Note several
labeled hepatocytes (arrows). (B) Splenic lymphoid follicle of a mouse euthanatized on day 3 PI. Labeling is primarily in foci of lymphocytes with other morphological changes
typical of apoptosis (shrunken cells, pyknosis). (C) Liver, uninfected control mouse. Note labeling of a single sinusoidal lining cell (arrow), morphologically consistent with a Kupffer
cell, likely undergoing physiologic apoptosis. (D) Spleen, uninfected control mouse, shows the presence of single labeled lymphocytes, consistent with physiologic apoptosis in a
normal animal.
266 D.R. Smith et al. / Virology 407 (2010) 256–267principles stated in the guide for the Care and Use of Laboratory
Animals, National Research Council, 1996. USAMRIID is fully accre-
dited by the Association for Assessment and Accreditation of
Laboratory Animal Care International.
Histopathology
Mice were euthanatized by perfusion (as described above) under
deep anesthesia. A complete necropsy was performed on each mouseFig. 11. Timeline of events during RVFV infection inmice. Mice were infected s.c. with 1000 P
succumb to disease on day 3 PI after infection of the liver and a peak in liver enzymes. The vir
animals dying of encephalitis around day 8 PI. White triangles symbolize when mice beginand a full complement of tissues, including brain and skull sections,
was collected. Tissues were ﬁxed in 10% neutral-buffered formalin for
a minimum of 21 days, then removed from biocontainment and
processed for routine histopathology. Tissue sections for histopathol-
ogy were stained by hematoxylin and eosin (HE).
Duplicate tissue sections were stained by immunohistochemistry
for RVFV antigen using a commercially available immunoperoxidase
method (EnVision System, DAKO Corp., Carpinteria, CA). Sections
were deparafﬁnized and pretreated with proteinase K for 6 minFU of RVFV on day 0. On day 2 PI, virus was detected in various tissues andmice began to
us appeared tropic for multiple tissues on day 5 PI followed by infection of the brain and
to succumb.
267D.R. Smith et al. / Virology 407 (2010) 256–267before incubation with the primary antibody (R1547—rabbit poly-
clonal anti RVFV), diluted 1:800 and incubated at room temperature
for 30 min. This was followed by incubation with a peroxidase-
conjugated, polymer-based, secondary antibody. Tissues stained by
IHC were examined microscopically to determine the types of cells
labeled for viral antigen. In addition, the amount of RVFV antigen in
the liver sections was measured by digital image analysis, with an
automated cell imaging system (ACIS II, DAKO Corp., Carpinteria, CA).
This system includes a bright-ﬁeld microscope coupled to a CCD
camera to detect levels of hue, saturation, and luminosity in individual
pixels. The learn-by-example feature of the system software was used
to train the system to separately recognize brown pixels (RVFV
antigen) and blue pixels (hematoxylin counterstain). Threshold
variables were adjusted until masked brown pixels visually correlated
with immunopositive cell cytoplasm and marked blue pixels
correlated with areas of pure counterstain. Separate data for percent
cells staining and percent intensity were determined.
A peroxidase-based terminal deoxynucleotidyl transferase biotin-
dUTP nick end labeling (TUNEL) method (ApopTag detection, S7100
kit; Chemicon/Millipore, Billerica, MA)was used to detect DNA strand
breaks in cells undergoing apoptosis in these tissues. Sections were
stained in accordance with kit instructions with the following
modiﬁcations: a 13-min room temperature protein digestion in
prediluted proteinase K (DAKO) was used. Slides were incubated in
equilibration buffer for 5 min, followed by incubation in working
strength terminal deoxynucleotidyl transferase (TdT) enzyme at 37 °C
for 60 min. This was followed by a stop/wash step and an anti-
digoxigenin peroxidase step, which were identical to kit instructions.
Color development was with DAB chromagen and then slides were
counterstained with hematoxylin. Sections were examined to deter-
mine the morphology of cell types undergoing apoptosis and were
subjectively scored.
Electron microscopy
All electron microscopy samples were ﬁxed and processed for
embedment in Epon-812 resin (EM Sciences, Gibbstown, NJ) and
examined using a transmission electron microscope. Brieﬂy, tissue
samples from threemice were taken each day and ﬁxed in cacodylate-
buffered 3% paraformaldehyde/1.5% glutaraldehyde for 24 hours at
4 °C. Tissues were then immersed and removed from biocontainment
in 1% veronal-buffered osmium tetroxide. Samples were then
dehydrated with graded series of ethanol washes and then inﬁltrated
with Epon-812 resin by graded washes of propylene oxide and resin.
Finally, blocks were polymerized for 48 hours at 60 °C, sectioned with
a Leica UC 6 ultramicrotome, and poststained with 2% uranyl acetate
and Reynold's lead citrate. Ultrathin sections were examined with a
JEOL JEM transmission electron microscope.
Statistics
SAS version 9.1.3 (SAS Institute Inc., Cary, NC) was used to
determine differences in the mean blood chemistry and hematology
results between day 0 (uninfected controls) and subsequent time
points using T-tests with step-down Bonferroni adjustment for
multiple comparisons. Tests of normality and homogeneity of
variance were satisﬁed.
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